189 related articles for article (PubMed ID: 17473372)
1. Brain metastases of breast cancer.
Palmieri D; Smith QR; Lockman PR; Bronder J; Gril B; Chambers AF; Weil RJ; Steeg PS
Breast Dis; 2006-2007; 26():139-47. PubMed ID: 17473372
[TBL] [Abstract][Full Text] [Related]
2. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
[TBL] [Abstract][Full Text] [Related]
3. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
[TBL] [Abstract][Full Text] [Related]
5. NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.
Adkins CE; Nounou MI; Hye T; Mohammad AS; Terrell-Hall T; Mohan NK; Eldon MA; Hoch U; Lockman PR
BMC Cancer; 2015 Oct; 15():685. PubMed ID: 26463521
[TBL] [Abstract][Full Text] [Related]
6. [Brain metastasis of breast tumors and blood brain barrier].
Diéras V; Pierga JY
Bull Cancer; 2011 Apr; 98(4):385-9. PubMed ID: 21527366
[TBL] [Abstract][Full Text] [Related]
7. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
Song HT; Jordan EK; Lewis BK; Liu W; Ganjei J; Klaunberg B; Despres D; Palmieri D; Frank JA
J Transl Med; 2009 Oct; 7():88. PubMed ID: 19840404
[TBL] [Abstract][Full Text] [Related]
8. Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer.
Samala R; Thorsheim HR; Goda S; Taskar K; Gril B; Steeg PS; Smith QR
Pharm Res; 2016 Dec; 33(12):2904-2919. PubMed ID: 27541873
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
Larsen PB; Kümler I; Nielsen DL
Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
[TBL] [Abstract][Full Text] [Related]
10. CNS complications of breast cancer: current and emerging treatment options.
Kaal EC; Vecht CJ
CNS Drugs; 2007; 21(7):559-79. PubMed ID: 17579499
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.
Gabos Z; Sinha R; Hanson J; Chauhan N; Hugh J; Mackey JR; Abdulkarim B
J Clin Oncol; 2006 Dec; 24(36):5658-63. PubMed ID: 17102066
[TBL] [Abstract][Full Text] [Related]
14. Current therapeutic options for breast cancer central nervous system metastases.
Hemphill MB; Lawrence JA
Curr Treat Options Oncol; 2008 Feb; 9(1):41-50. PubMed ID: 18392684
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
16. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.
Askoxylakis V; Ferraro GB; Kodack DP; Badeaux M; Shankaraiah RC; Seano G; Kloepper J; Vardam T; Martin JD; Naxerova K; Bezwada D; Qi X; Selig MK; Brachtel E; Duda DG; Huang P; Fukumura D; Engelman JA; Jain RK
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547932
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer brain metastases.
Cheng X; Hung MC
Cancer Metastasis Rev; 2007 Dec; 26(3-4):635-43. PubMed ID: 17717635
[TBL] [Abstract][Full Text] [Related]
19. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine modulates breast cancer metastasis to the brain in a murine model.
Shapovalov Y; Zettel M; Spielman SC; Amico-Ruvio SA; Kelly EA; Sipe GO; Dickerson IM; Majewska AK; Brown EB
BMC Cancer; 2014 Aug; 14():598. PubMed ID: 25129445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]